Buy-Sell Agreement
Life Insurance: Fund the
Buyout Before You Need It
If your business partner dies tomorrow, their equity passes to their spouse. You are suddenly in business with a grieving widow who wants cash you do not have, controls votes you cannot afford to lose, and has no obligation to sell at a price you can pay. A properly funded Buy-Sell Agreement with life insurance eliminates this scenario entirely — converting a catastrophic ownership crisis into a clean, contractually predetermined equity transfer that closes within days of the death certificate.
1. The Scenario That Destroys Partnerships: What Actually Happens Without a Funded Buy-Sell
The moment a business partner dies, their ownership interest does not disappear. It does not return to the company. It does not automatically transfer to the surviving partners. It passes, with full legal force, to whoever is named in the deceased partner’s will — and in the vast majority of cases, that person is their surviving spouse. The spouse inherits not just the equity stake but all the rights that attach to it: voting rights, rights to inspect company books, rights to receive distributions, and the right to demand a buyout at a price of their choosing on a timeline of their choosing.
The surviving business partners have no automatic legal remedy. They cannot force a sale. They cannot override the inherited voting rights. They cannot value the business unilaterally and demand the estate accept that number. What follows is not a clean business transaction — it is a negotiation conducted between grieving family members and their own business partners, with tens of thousands of dollars in legal fees accumulating on both sides, business decisions paralyzed by disputed ownership, and key employees watching the chaos and updating their resumes.
The Ownership Crisis That Unfolded Over 31 Months
2. How a Funded Buy-Sell Agreement Works: The Four-Party Mechanism
A buy-sell agreement is a legally binding contract between business co-owners that governs what happens to each owner’s equity interest upon a specified triggering event — most commonly death, permanent disability, voluntary departure, divorce, or bankruptcy. The insurance policy is the funding mechanism that makes the agreement financially executable: it ensures that when the triggering event occurs, the cash required to complete the equity purchase is immediately available without requiring the surviving partners or the company to self-fund a transaction that may be worth millions of dollars.
The agreement creates a contractual obligation that binds all parties: the surviving owners are obligated to purchase the deceased owner’s equity, and the estate is obligated to sell it. Neither party has the option to refuse. The price and the methodology for calculating it are established in advance, eliminating the valuation dispute that destroys so many unprotected partnerships. The insurance proceeds fund the purchase price, eliminating the liquidity crisis that forces surviving partners to take on debt or sell assets to complete the buyout. The result is an equity transfer that typically completes within 30 to 60 days of the triggering event — rather than 31 months of litigation.
Cross-Purchase Structure — Funds Flow on Partner Death
Owns policy on Partner B
Annually to carrier
Issues policy on Partner B’s life
Tax-free to Partner A
Receives buyout funds
Per agreed valuation formula
Receives cash, surrenders all equity
3. Cross-Purchase vs. Entity Redemption: The Structure Decision That Determines Tax Outcome
The most consequential structural decision in a funded buy-sell agreement is whether to use a cross-purchase structure or an entity redemption structure. This choice determines how many insurance policies are needed, who owns and pays for each policy, and — most critically — whether the surviving partners receive a stepped-up cost basis in the acquired shares. The basis question is not an administrative detail. For a business that continues to appreciate in value after the buyout, the cost basis difference between the two structures can determine whether the surviving partner pays capital gains taxes on hundreds of thousands of dollars when they eventually sell the business.
4. Establishing the Buyout Price: Three Methods and Why Your Agreement Must Specify One
The buy-sell agreement’s value as a succession planning instrument depends entirely on whether the buyout price can be determined without dispute at the time of the triggering event. An agreement that specifies that the buyout price will be determined by negotiation at the time of the event provides almost no protection — it simply reproduces the default scenario of negotiation between the estate and the surviving partners, with the additional twist that both parties are now contractually obligated to reach a number they may never agree on. A properly drafted buy-sell agreement specifies the valuation methodology in advance and leaves no discretion to the parties at the time of the triggering event.
Calculate Your Buy-Sell Policy Face Value From Your Business Valuation
Our Key Person Insurance Valuation Calculator applies your EBITDA multiple, ownership percentages, and partner ages to generate the exact policy face value and annual premium for each partner in a cross-purchase or entity redemption structure.
5. The Multi-Partner Policy Count Problem and How to Solve It
For partnerships with more than two owners, the cross-purchase structure’s policy count grows with the square of the number of partners, creating administrative complexity that frequently causes companies to abandon the cross-purchase structure or to fail to maintain all required policies over time. Understanding the policy count math and the practical solutions that address it is essential for any partnership with three or more owners considering a buy-sell agreement structure.
6. The Financial Outcome: Two-Partner Buyout With and Without Insurance Funding
The financial difference between a funded and unfunded buy-sell agreement is not an abstract discussion of legal risk. It is a concrete, calculable cash flow and net worth impact that can be modeled for any specific partnership. The scenarios below apply to the same two-partner manufacturing company at the same valuation — the only variable is whether the buy-sell agreement is funded with life insurance or left unfunded.
Financial Impact on Surviving Partner — $4.0M Business, 50/50 Ownership, Unfunded Agreement
Financial Impact on Surviving Partner — Same $4.0M Business, Insurance Funded at $2.0M Per Partner
7. The Trigger Most Buy-Sell Agreements Miss: Permanent Disability
Most business owners instinctively design their buy-sell agreement around the death trigger — which is the least probable triggering event for most partners under age 60. A 45-year-old business owner is approximately four times more likely to suffer a long-term disability lasting more than 90 days before age 65 than they are to die before age 65. A buy-sell agreement that is funded only for death, and has no funding mechanism for permanent disability, is half of a succession plan — it protects against the less likely event while leaving the more likely event entirely unfunded.
| Partner Age | Probability of Death Before 65 | Probability of 90-Day+ Disability Before 65 | Disability:Death Ratio | Recommended Funding Priority |
|---|---|---|---|---|
| 35 years old | 4.2% | 21.8% | 5.2× more likely disabled | Disability buyout funding is the primary risk; life insurance is secondary |
| 42 years old | 6.8% | 24.1% | 3.5× more likely disabled | Both disability and life funding required; disability premium is typically lower than life at this age |
| 50 years old | 11.4% | 27.3% | 2.4× more likely disabled | Approximately equal funding priority — both triggers carry material probability |
| 58 years old | 19.2% | 24.7% | 1.3× more likely disabled | Death probability has increased substantially — life insurance becomes proportionally more important |
| 63 years old | 28.1% | 21.4% | 0.76× — death now more probable | Life insurance is the primary funding mechanism; disability coverage term may be shorter to age 65 |
8. The Stale Valuation Problem: Why Annual Reviews Are a Legal and Financial Obligation
A buy-sell agreement executed today with a life insurance policy sized to the current business valuation is a sound succession plan today. Without an annual review and policy update process, it becomes a progressively more dangerous document as the business grows and the insurance coverage falls further behind the actual equity value it is supposed to fund. An underfunded buy-sell agreement — where the death benefit is $1.5 million but the partner’s equity is now worth $2.8 million — produces a partial buyout that forces the surviving partner to finance the gap or renegotiate with the estate, recreating exactly the scenario the agreement was designed to prevent.
A professional services partnership established a buy-sell agreement in 2019 with cross-purchase life insurance policies sized at $1,200,000 per partner — equal to each partner’s 50% equity value at a $2,400,000 business valuation. The agreement used the fixed agreed value method and was never updated. By 2025, the business had grown to a $4,400,000 valuation — nearly doubling in six years of strong growth. Each partner’s equity was now worth $2,200,000, but the insurance policies remained at $1,200,000. When one partner died unexpectedly in 2025, the surviving partner received $1,200,000 in death benefit — enough to fund 54.5% of the $2,200,000 buyout price required by the valuation. The surviving partner was forced to finance the remaining $1,000,000 gap at commercial rates, defeating the entire purpose of the insurance-funded agreement. The annual premium increase required to bring each policy from $1,200,000 to $2,200,000 for a 51-year-old partner in 2025 would have been approximately $4,100 per year — a cost the partners had never reviewed because no annual review calendar was established at agreement execution.
9. The Implementation Protocol: From Partnership Agreement to Funded Buy-Sell in 8 Steps
Implementing a funded buy-sell agreement requires coordination between three professional disciplines — legal counsel (to draft the agreement), a business valuation consultant or CPA (to establish and document the buyout price methodology), and a commercial insurance broker (to structure and place the funding policies). The protocol below sequences these three workstreams in the correct order to avoid the common mistake of placing insurance before the agreement is drafted, which can create a policy structure that does not match the agreement’s requirements.
The first decision — cross-purchase vs. entity redemption — determines who will own the policies, who will pay the premiums, and the tax treatment of both the premiums and the proceeds. This decision must be made by the partners in consultation with their tax advisor before a broker is engaged, because the broker’s policy design depends entirely on the ownership structure. Changing from entity redemption to cross-purchase after policies are issued requires surrendering and reissuing policies, triggering new medical underwriting for all covered partners. Make the structure decision first; place the insurance second.
The buy-sell agreement must specify the valuation methodology in sufficient detail that both parties — and a court, if necessary — can apply it to calculate the buyout price without discretion. For EBITDA multiple methods, the agreement must specify whether EBITDA is calculated before or after ownercompensation adjustments, which trailing period applies (12 months, 36-month average, or last fiscal year), and whether normalized EBITDA adjustments for non-recurring items are permitted. For fixed value methods, the agreement must specify the annual update procedure, who has authority to initiate the update, and what happens if partners disagree on the updated value. The valuation methodology section is the most frequently litigated clause in buy-sell agreements — invest the time and professional fees to make it unambiguous before executing the document.
The buy-sell agreement must be fully executed before the insurance applications are submitted. The agreement governs the insurance structure — not the reverse. Drafting typically requires 3 to 6 weeks with experienced business succession counsel and should cover all triggering events including death, permanent disability, voluntary departure, involuntary departure (termination for cause), divorce of a partner, personal bankruptcy of a partner, and an unsolicited third-party acquisition offer. Each triggering event may have different valuation methodologies and funding mechanisms — death and disability are typically insurance-funded, while voluntary departure buyouts are funded from the company’s cash flow or a sinking fund.
Once the agreement is executed and the valuation formula is documented, apply it to calculate each partner’s current equity value. This number becomes the required face value for each partner’s policy. For a cross-purchase structure with two partners, two face values are required — one for the policy on each partner’s life. For entity redemption with four partners, four face values are required, one for each partner’s company-owned policy. Use the Key Person Insurance Valuation Calculator to model the required face values across cross-purchase and entity redemption structures simultaneously before contacting carriers.
Submit applications to at least 3 competing carriers for each policy position simultaneously, rather than sequentially. For a two-partner cross-purchase structure, both partners should be applying at the same time so that underwriting decisions for both partners arrive in the same window. If one partner receives a substandard table rating from one carrier, competing quotes from other carriers frequently produce a better rating class for the same health profile — inter-carrier variation in underwriting standards can produce premium differences of 20 to 40% for identical health information. Never accept the first underwriting offer on a buy-sell policy without shopping at minimum three competing carriers.
If the entity redemption structure is used, the company must execute the IRC Section 101(j) employer-owned life insurance notice and consent documentation for each insured partner before the policies are issued. This requires: a written notice to each insured partner stating the company’s intent to insure their life, the maximum face value, and that the company will be the beneficiary; and a signed written consent from each insured partner acknowledging the notice and agreeing to the coverage. Retain the signed consent forms in the company’s permanent corporate records alongside the executed buy-sell agreement. Failure to comply with Section 101(j) results in the death benefit above the company’s basis being taxable — eliminating the tax-free character of the proceeds that is the entire financial basis for insurance-funded buy-sell agreements.
Upon policy issuance, verify that every policy reflects the correct ownership and beneficiary structure for the chosen buy-sell structure. In a cross-purchase structure, Partner A owns the policy on Partner B’s life and is the named beneficiary — not Partner A’s spouse, not the company, and not a trust unless the trust is specifically designed as the cross-purchase vehicle. In an entity redemption structure, the company is both the owner and beneficiary of every policy. Deliver a copy of every issued policy, the buy-sell agreement, and the valuation documentation to each partner’s personal estate planning attorney for coordination with their individual estate plans.
The single most important administrative step is establishing who is responsible for initiating the annual buy-sell review, when it occurs, and what triggers an off-cycle review. Designate a specific partner or the company’s CFO as the buy-sell plan administrator. Set a recurring Q4 calendar event for the annual review. Define the off-cycle review triggers: any acquisition offer, any new financing event that materially changes the company’s debt load, any addition or departure of a partner, and any year in which EBITDA changes by more than 20% from the prior year. The review must result in a documented written conclusion — either confirming that current policy face values remain adequate or specifying the policy increases required and the timeline for implementing them.
10. The Seven Buy-Sell Agreement Drafting Errors That Void the Protection
A buy-sell agreement that is poorly drafted can be as dangerous as no agreement at all — it creates a false sense of protection while containing provisions that are legally unenforceable, financially unworkable, or operationally ambiguous at exactly the moment they need to function perfectly. The errors below are drawn from business succession litigation and documented corporate estate planning failures. Each one is preventable with proper legal counsel and coordinated review between the drafting attorney and the insurance advisor.
| # | Drafting Error | What Goes Wrong at the Triggering Event | Prevention |
|---|---|---|---|
| 1 | Valuation by negotiation — agreement states that buyout price “shall be determined by mutual agreement of the parties at the time of the triggering event” | Parties cannot agree. Agreement provides no dispute resolution mechanism. The document that was supposed to eliminate negotiation simply postpones it to the worst possible moment, with both parties now contractually bound to reach a number they may never agree on. | Specify the valuation methodology in full in the agreement itself. Include a tiebreaker provision: if parties cannot agree within 30 days, a jointly selected NACVA-certified appraiser’s determination is binding. |
| 2 | Insurance policies not coordinated with agreement — policies are placed before the agreement is executed, using face values, ownership structures, or beneficiary designations that conflict with the final agreement terms | Death benefit flows to the wrong party, in the wrong amount, under the wrong ownership structure — requiring policy reformation that takes months and may require new underwriting. | Execute the agreement first. Issue policies after. Require the insurance broker to review the final executed agreement before submitting any applications. |
| 3 | Disability trigger period misaligned with policy elimination period — agreement defines permanent disability as 12 months but disability buyout policy has 24-month elimination period | The buyout obligation is triggered by the agreement at month 12 but the insurance proceeds are not payable until month 24. Surviving partners must fund the buyout from personal or business funds for 12 months before the insurance reimburses them — defeating the liquidity purpose of the insurance. | The disability buy-sell elimination period must exactly match the agreement’s definition of permanent disability. Coordinate this in writing between the attorney and the broker before any documents are executed. |
| 4 | No provision for partnership interest adjustment when one partner partially exits — a partner sells 15% of their 40% stake to a new investor, reducing their stake to 25%, but the buy-sell agreement and the insurance policies still reflect the original 40% equity value | Upon death, the surviving partners are contractually obligated to purchase a 40% equity stake at the 40% valuation, but the deceased partner only owned 25% at time of death. Overpayment dispute, estate litigation, and insurance proceeds exceeding the actual buyout obligation create tax complications. | Include a mandatory policy and agreement adjustment provision triggered by any ownership percentage change exceeding 5 percentage points. Assign the CFO responsibility for initiating the adjustment within 60 days of any equity transfer. |
| 5 | Buy-sell agreement does not address the surviving partner’s subsequent estate plan — surviving partner owns 100% of business after buyout but has no estate plan for their now-100% stake, recreating the exact problem that was just solved for the original partnership | Surviving partner dies with 100% equity in the business, no buy-sell agreement covering their solo ownership, and no succession mechanism — their heirs inherit a 100% stake in a business with no liquidity mechanism, exactly replicating the original problem at a larger scale. | Require each partner’s estate attorney to review and update their individual estate plan within 90 days of the buy-sell agreement execution. Include a provision obligating surviving partners to establish new coverage arrangements within 12 months of becoming a sole owner. |
| 6 | Policy lapse due to uncoordinated premium payment responsibility — in a cross-purchase structure, each partner is individually responsible for paying their own policy premiums, but no monitoring system exists and one partner allows their policy to lapse after a personal financial difficulty | One partner’s policy lapses without the other’s knowledge. The partner whose policy has lapsed dies. The surviving partner discovers the lapse while attempting to claim the death benefit — with no proceeds available to fund the mandatory buyout obligation and no time to obtain new coverage on a deceased insured. | Require each partner to provide annual written confirmation of premium payment status to the plan administrator. Include a cross-notification provision requiring carriers to notify all policy owners of any lapse or grace period notice on any policy that is part of the buy-sell arrangement. |
| 7 | Agreement does not specify what happens to the insurance policy if the buy-sell is terminated by mutual consent or business sale — policies are outstanding on partners’ lives with no ownership transfer mechanism when the business is sold | Business is sold. Buy-sell agreement is dissolved. Cross-purchase policies remain in force but are now owned by one partner on the other’s life with no business relationship justifying the arrangement. Insurable interest issues, estate planning complications, and potential gift tax exposure from policy transfer between former partners. | Include a policy disposition provision in the agreement specifying that upon dissolution, each insured partner has a right of first refusal to purchase at cash surrender value any policy owned by their co-partners on their own life, exercisable within 60 days of the dissolution event. |
Calculate Your Buy-Sell Policy Face Value From Your Partnership Valuation
Enter your business EBITDA, valuation multiple, and ownership percentages. Our Key Person Insurance Valuation Calculator generates the exact face value required for each partner under both cross-purchase and entity redemption structures, with premium comparisons across carrier tiers.
Open Buy-Sell Calculator →Frequently Asked Questions
How does life insurance fund a buy-sell agreement?
Life insurance funds a buy-sell agreement by providing an immediate, tax-free cash payment to either the surviving business owners or the company itself upon the death of an owner — with those proceeds contractually obligated to purchase the deceased owner’s equity interest from their estate at a pre-agreed valuation. Without insurance funding, the surviving owners must either pay the buyout price from personal funds or business cash reserves they may not have, take on commercial debt to finance the buyout, or negotiate with the deceased owner’s heirs who have no obligation to sell quickly or at a favorable price. With insurance funding, the death benefit arrives within days of the claim, the buyout proceeds go directly to the estate, the surviving owners receive the equity shares, and business continuity is preserved without cash flow disruption or debt.
What is the difference between cross-purchase and entity redemption?
In a cross-purchase buy-sell agreement, each business owner individually purchases and owns a life insurance policy on every other owner, with themselves named as beneficiary. When an owner dies, the surviving owners receive the death benefit personally and use it to purchase the deceased owner’s equity directly from the estate — receiving a stepped-up cost basis in the acquired shares equal to the purchase price paid. In an entity redemption buy-sell agreement, the business itself purchases and owns one life insurance policy on each owner, with the company named as beneficiary. When an owner dies, the company receives the death benefit and redeems the deceased owner’s equity from the estate, with surviving owners’ percentage stakes automatically increasing. The key practical difference is the stepped-up cost basis in cross-purchase — which can save hundreds of thousands of dollars in capital gains taxes at future exit — versus the administrative simplicity of entity redemption, which scales more easily for partnerships with four or more owners.
How much life insurance do I need for a buy-sell agreement?
The life insurance face value required for a buy-sell agreement equals each owner’s proportionate share of the agreed business valuation. For a two-owner 50/50 partnership with an agreed business valuation of $4,000,000, each policy must have a minimum face value of $2,000,000 — representing each owner’s 50% equity interest. The agreed valuation should be established using a recognized methodology — most commonly an EBITDA multiple, a discounted cash flow analysis, or an annual fixed value agreed by all partners. Policy face values must be reviewed and updated at least every 3 years to prevent the underfunded buyout scenario where the insurance proceeds cover only a fraction of the actual equity value at the time of the triggering event.
What happens if there is no buy-sell agreement when a business partner dies?
When a business partner dies without a funded buy-sell agreement, the deceased partner’s ownership interest passes to their estate and ultimately to their heirs under the terms of their will or state intestacy laws. The surviving business owners have no automatic legal right to purchase the inherited equity interest, no guaranteed valuation methodology, and no funding mechanism. The result is typically a forced co-ownership with the deceased partner’s heirs, who may have conflicting financial objectives or a desire to liquidate their inherited interest at a price the surviving owners cannot afford to pay. This scenario frequently results in protracted legal disputes lasting 2 to 3 years, forced business liquidations, or distressed buyouts at prices that destroy significant business value — all of which are eliminated by a properly funded buy-sell agreement.
Can a buy-sell agreement be funded with disability insurance instead of life insurance?
Yes, and for most business owners under age 55, disability is actually a more statistically probable triggering event than death — roughly 3 to 5 times more likely for partners in their 30s and 40s. A disability buyout policy provides a lump sum or installment payment to fund the buyout of a permanently disabled owner’s equity interest once a specified elimination period — typically 12 to 24 months of continuous total disability — is satisfied. The elimination period in the disability insurance policy must exactly match the waiting period in the buy-sell agreement’s definition of permanent disability to avoid a funding gap. For comprehensive partner succession planning, both life and disability buy-sell funding are required — life insurance for the death trigger and disability buyout insurance for the permanent disability trigger.
How does life insurance fund a buy-sell agreement?
Life insurance funds a buy-sell agreement by providing an immediate, tax-free cash payment to either the surviving business owners or the company itself upon the death of an owner — with those proceeds contractually obligated to purchase the deceased owner’s equity interest from their estate at a pre-agreed valuation. Without insurance funding, the surviving owners must either pay the buyout price from personal funds or business cash reserves they may not have, take on commercial debt to finance the buyout, or negotiate with the deceased owner’s heirs — who have no obligation to sell quickly or at a favorable price. With insurance funding, the death benefit arrives within days of the claim, the buyout proceeds go directly to the estate, the surviving owners receive the equity shares, and business continuity is preserved without cash flow disruption or debt.
What is the difference between a cross-purchase and entity redemption buy-sell agreement?
In a cross-purchase buy-sell agreement, each business owner individually purchases and owns a life insurance policy on every other owner, with themselves named as beneficiary. When an owner dies, the surviving owners receive the death benefit personally and use it to purchase the deceased owner’s equity directly from the estate. In an entity redemption buy-sell agreement, the business itself purchases and owns one life insurance policy on each owner, with the company named as beneficiary. When an owner dies, the company receives the death benefit and uses it to redeem the deceased owner’s equity from the estate, with the surviving owners’ percentage stakes automatically increasing pro-rata. The key practical difference is that cross-purchase agreements give surviving owners a stepped-up cost basis in the acquired shares — valuable for future capital gains tax calculations — while entity redemption agreements involve simpler policy administration with fewer policies required, particularly in partnerships with more than two owners.
How much life insurance do I need for a buy-sell agreement?
The life insurance face value required to fund a buy-sell agreement equals each owner’s proportionate share of the agreed business valuation. For a two-owner 50/50 partnership with an agreed business valuation of $4,000,000, each policy must have a minimum face value of $2,000,000 — representing each owner’s 50 percent equity interest. The agreed business valuation should be established using a recognized valuation methodology — most commonly a multiple of EBITDA, a discounted cash flow analysis, or an agreed fixed formula stated in the buy-sell agreement itself. The policy face value should be reviewed and updated at least every 3 years, or following any material change in business value, to prevent an underfunded buyout in which the insurance proceeds are insufficient to purchase the full equity interest at the then-current business value.
What happens if there is no buy-sell agreement when a business partner dies?
When a business partner dies without a funded buy-sell agreement in place, the deceased partner’s ownership interest passes to their estate and ultimately to their heirs — most commonly their surviving spouse — under the terms of their will or state intestacy laws. The surviving business owners have no automatic legal right to purchase the inherited equity interest, no guaranteed valuation methodology, and no funding mechanism. The result is a forced co-ownership with the deceased partner’s heirs, who may have no business expertise, conflicting financial objectives, or a desire to liquidate their inherited interest at a price the surviving owners cannot afford to pay. This scenario frequently results in protracted legal disputes, forced business liquidations, or distressed buyouts at prices that destroy significant business value. A properly funded buy-sell agreement eliminates every one of these outcomes by contractually obligating all parties to complete the equity transfer at a predetermined price, funded by the insurance proceeds that arrive within days of the death.
